American Vanguard (NYSE:AVD) Issues Quarterly Earnings Results

American Vanguard (NYSE:AVD) released its quarterly earnings data on Monday. The basic materials company reported ($0.61) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.60), Zacks reports. American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.

American Vanguard Stock Performance

Shares of AVD stock traded down $0.14 during trading hours on Monday, hitting $0.82. The stock had a trading volume of 730,060 shares, compared to its average volume of 333,527. The firm has a market capitalization of $24.13 million, a PE ratio of -0.43 and a beta of 1.56. American Vanguard has a twelve month low of $0.81 and a twelve month high of $5.55. The stock’s 50 day moving average is $1.66 and its 200 day moving average is $2.80. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.47 and a quick ratio of 1.40.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of American Vanguard in a report on Thursday, August 13th. Wall Street Zen lowered shares of American Vanguard from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, American Vanguard presently has a consensus rating of “Sell”.

Insider Buying and Selling

In related news, Director Keith M. Rosenbloom sold 556,580 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $2.20, for a total value of $1,224,476.00. Following the completion of the sale, the director owned 15,201 shares in the company, valued at $33,442.20. This represents a 97.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven D. Macicek purchased 19,000 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were acquired at an average price of $2.09 per share, with a total value of $39,710.00. Following the purchase, the director owned 99,711 shares in the company, valued at $208,395.99. This trade represents a 23.54% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Company insiders own 5.60% of the company’s stock.

About American Vanguard

American Vanguard Corporation, doing business primarily through its AMVAC subsidiary, develops, manufactures and markets specialty agricultural products. The company’s portfolio includes crop protection products such as insecticides, herbicides, fungicides, nematicides and soil fumigants designed to help growers manage pests, weeds and plant diseases.

In addition to crop protection, American Vanguard serves the professional and consumer markets for turf and ornamental care, golf course management, pest control and public health.